“Cognitive enhancement drugs only have short-term benefits and can cause significant side-effects for people with mild memory problems, according to researchers. In a new review of existing data, researchers at St. Michael’s Hospital in Toronto, Canada studied eight randomized clinical trials and three companion reports on the efficacy of four drugs in people with mild cognitive impairment. The drugs were donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), and memantine (Namenda). They found that while the drugs do have short-term benefits, they are lost after a year and a half of treatment.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Goodbye Silk Road, Hello Sheep Marketplace
Tamir Rice Protesters March to Prosecutor's Home, Demand Resignation
Fed Tapers Another $10 Billion, Expecting Rebound From Grim Q1
Calif. legislature will force schools to teach Russians hacked 2016 election
European defense contractors ask governments to launch drone programs
Judge orders trial in allegedly missing Oklahoma City bombing video case
Republican battles for Medicaid funding turn to God and morality
FBI is investigating former Utah trooper Lisa Steed
FBI a ‘secret domestic intelligence agency,’ ACLU says
Rand Paul: Blame Dick Cheney for Iraq violence, not Obama
Report: Assad agreed to quit on own conditions, US refused
Bin Laden son-in-law court appearance reignites debate over handling of terrorism cases
Homebuilder helping Millennials trade student loan debt for house debt
Would you download a car? Man 3D prints life-size Aston Martin DB4
FHA exhausts reserves, may need bailout